Medical News

RSS

Higher status positions can have negative impact on personal health

Being at the top has its perks, but new UofT research shows people in positions of authority at work are more likely to experience certain psychological and physical problems that can undermine the health benefits associated with job authority.

20 Oct 2009

Study explores the link between LUTS and depression, anxiety disorders, sexual trauma

Depression, anxiety disorders and sexual trauma have all been implicated as risk factors in lower urinary tract symptoms (LUTS) such as incontinence and overactive bladder.

20 Oct 2009

AstraZeneca and POZEN announce the pivotal data from two POZEN clinical trials

AstraZeneca and POZEN Inc. today announced pivotal data from two POZEN clinical trials that were presented at the American College of Rheumatology (ACR) 2009 Annual Scientific Meeting in Philadelphia, PA.

20 Oct 2009

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals Inc. announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone.

20 Oct 2009

UHC selects RGIS to streamline inventory counting services

The University HealthSystem Consortium (UHC) today announced that it has awarded a 3-year agreement to RGIS, based in Auburn Hills, Mich, for inventory counting services. The agreement, which has 2 automatic 1-year renewal periods, became effective on September 1, 2009.

20 Oct 2009

Benefit Express collaborates with National Student Clearinghouse for student status verification services

Benefit Express, a Benefit Administration Outsourcing service provider, has partnered with National Student Clearinghouse® to allow My Benefit Express(TM) subscribers to validate full-time student status. The partnership allows Benefit Express clients to validate the full-time student status of all dependents at more than 2,400 accredited colleges and universities in the United States, representing more than 80% of U.S. total enrollment electronically.

20 Oct 2009

Investment opportunities in the global patient monitoring market thru 2015

MarketResearch.com has announced the addition of Global Markets Direct's new report "Global Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015," to their collection of Patient Monitoring market reports.

20 Oct 2009

NicOx presents data on its phase 3 naproxcinod study at the ACR meeting

NicOx S.A. announced the presentation of detailed 26-week efficacy, safety and tolerability data from the second pivotal phase 3 study for naproxcinod (the 302 study) yesterday, at the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.

20 Oct 2009

Philips launches DirectLife fitness program to deliver health benefits

Philips is delivering on their commitment to be the leader in health and well-being with the launch of Philips DirectLife, a new customized, interactive fitness program that offers a fun and simple solution to people eager to adopt a more active lifestyle.

20 Oct 2009

Family structure does not impact adolescents' behaviors

The conventional family has changed over the past decade. According to a new study by the Working Group on Adolescence of the Andalusian Society of Family and Community Medicine, which has been published in the Spanish journal Atenci-n Primaria, adolescents' perception of proper family functioning has little to do with the traditional nuclear structure.

20 Oct 2009

Patheon, Lonza Group mutually agree to terminate discussions

The Special Committee of Independent Directors of Patheon Inc. today announced that Lonza Group AG ("Lonza") has withdrawn its previously announced non-binding proposal to acquire all of the outstanding restricted voting shares of the Company. In addition, the Special Committee and Lonza have mutually agreed to terminate discussions regarding other possible strategic transactions between Lonza and Patheon.

20 Oct 2009

Rexahn Pharmaceuticals announces positive results from Phase IIa Serdaxin clinical study

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in CNS and oncology, today announced top-line results from a Phase IIa clinical study of Serdaxin™, its major depressive disorder (MDD) drug candidate.

20 Oct 2009

Menarini granted exclusive European licence rights to Ipsen's Adenuric

Ipsen, an innovation-driven global specialty pharmaceutical group, announced an agreement whereby Ipsen grants the Menarini Group the exclusive licence rights to Adenuric® (febuxostat) in 41 countries. Ipsen retains co-promotion rights for Adenuric® in France.

20 Oct 2009

Virtual Reality Exposure Treatment to help tackle driving phobias

Researchers at The University of Manchester have recruited volunteers with a variety of driving phobias to test whether virtual reality can be used alongside conventional psychological therapies to help tackle their fears.

From The University of Manchester 20 Oct 2009

OrSense presents data on its NBM-200MP system for hemoglobin and blood oximetry measurements

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, presented today at the American Association of Anesthesiologists (ASA) annual meeting, in New Orleans. The results from a multi-center study indicate that NBM-200MP, a continuous, non-invasive monitoring system, measures levels of oxygen saturation and hemoglobin accurately and reliably in comparison to accepted methods.

20 Oct 2009

Origene Technologies' acquisition of Marligen Biosciences reinforces its leading position in the bio-medical research industry

OriGene Technologies, Inc. today announced the acquisition of Marligen Biosciences, Inc., a provider of cutting-edge multiplex assays for the Luminex xMAP(R) platform for protein and gene expression profiling assays and testing services, and DNA and RNA purification kits.

20 Oct 2009

New research emphasizes benefits of exercise on brain and related disorders

Research presented today at Neuroscience 2009, the annual meeting of the Society for Neuroscience (SfN) and the world's largest source of emerging news about brain science and health, provides a better understanding of the brain, nervous system, and related disorders.

20 Oct 2009

Novel H1N1 influenza raises parents' awareness and concern about seasonal influenza

Novel H1N1 influenza has raised parents' awareness and concern about seasonal influenza, increasing the likelihood that they will get their children vaccinated compared to past years, according to a recent national survey commissioned by the National Foundation for Infectious Diseases (NFID).

20 Oct 2009

AAP's initiative to address childhood asthma

With chronic diseases on the rise in children, pediatricians are looking for solutions to improve care and outcomes for these often complex illnesses. The American Academy of Pediatrics (AAP) today announced a new initiative funded with a grant from the Merck Childhood Asthma Network, Inc. (MCAN) that will allow pediatricians across the country to pilot a series of quality improvement programs to effectively address the top chronic disease affecting kids - childhood asthma.

20 Oct 2009

Rexall Diabetes Starter Kit for newly diagnosed patients

Over 40 per cent of Canadians diagnosed with a life-threatening disease, such as diabetes, feel confused or overwhelmed after leaving their doctor's office, shows a Leger Marketing survey commissioned by the Rexall family of pharmacies.

20 Oct 2009